Ligand validation:7XMB

PEK: (1S)-2-{[(2-AMINOETHOXY)(HYDROXY)PHOSPHORYL]OXY}-1-[(STEAROYLOXY)METHYL]ETHYL (5E,8E,11E,14E)-ICOSA-5,8,11,14-TETRAENOATE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7XMB_PEK_G_101	33%	45%	0.227	0.905	0.93	1.18	2	5	3	0	100%	1
7XMB_PEK_P_306	29%	42%	0.227	0.888	0.94	1.28	2	6	6	0	100%	1
7XMB_PEK_P_301	3%	87%	0.296	0.614	0.27	0.42	-	-	2	0	100%	1
7XMB_PEK_C_306	1%	43%	0.345	0.512	0.86	1.34	2	9	5	0	100%	1
7XMB_PEK_B_604	1%	39%	0.375	0.512	0.91	1.45	2	8	4	0	100%	1
7XMB_PEK_C_309	0%	47%	0.491	0.492	0.92	1.14	2	5	7	0	100%	1
5B1A_PEK_G_101	93%	28%	0.08	0.973	1.2	1.66	5	12	8	0	100%	1
7YPY_PEK_C_307	85%	53%	0.095	0.963	0.76	1.05	1	3	9	0	98%	1
7VVR_PEK_P_303	82%	52%	0.106	0.961	0.69	1.14	2	5	5	0	100%	1
7VUW_PEK_C_303	82%	50%	0.109	0.964	0.67	1.23	1	5	5	0	100%	1
5B3S_PEK_C_302	81%	47%	0.118	0.97	0.85	1.18	2	3	9	0	100%	1
7D5X_PEK_C_304	81%	49%	0.12	0.971	0.85	1.13	2	2	12	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.